Conduct disorder

Recommendations

Info

Dafina Kuzmanovska 11. Feather AS, Malcolm S, Woolf A, et al: Primary nonsyndromatic vesicoureteric reflux and its nephropathy are genetically heterogeneous, with locus on chromosome 1. Am.J.Hum.Genet. 2000; 66:1420-1425 12. Conte ML at al: A genome search for primary vesicoureteral reflux shows further evidence for genetic heterogeneity. Pediatr Nephrol (2008) 23: 587- 595) 13. Adrian S Woolf: A molecular and genetic view of human renal and urinary tract malformations. Kidney International (2000) 58, 500–512 14. John C Pope, at all: How They Begin and How They End - Classic and New Theories for the Development and Deterioration of Congenital Anomalies of the Kidney and Urinary Tract, CAKUT. J Am Soc Nephrol 10:2018-2028, 1999 15. Hohenfellner K, Hunley TE, Brezinsky R at al: ACE I/D gene polymorphism predicts renal damage in congenital uropathies. Pediatric Nephrol 1999, 13:514-518 16. Rigoli L at all: Angiotensin-Converting Enzyme and Angiotensin Type 2 Receptor Gene Genotype Distributions in Italian Children with Congenital Uropathies Pediatric Research:Volume 56(6)December 2004pp 988-993 17. Milan Chromek and Annelie Brauner: Urinary Tract Infection. Why Do Some Children Get Complications,While Others Don’t? Current Pediatric Reviews, 2007, 3, 35-44 35 Страна 90
Novini vo pedijatrijata / Godi[na revija 2009 NEALKOHOLNA MASNA BOLEST NA CRNIOT DROB Kostovski Aco Univerzitetska klinika za detski bolesti Skopje Voved Steatozata pretstavuva akumulacija na masti vo hepatocitite i se sretnuva vo mnogu hepatalni bolesti. Spored goleminata na masnite kapki razlikuvame makrovezikularna steatoza, kaj koja hepatocitite se ispolneti so edna golema masna kapka i mikrovezikularna steatoza vo koja hepatocitite se ispolneti so mnogu sitni masni kapki, koi mu davaat penu[est izgled na hepatocitot. Pokraj akumulacijata na masti moè da postojat i inflamatorni promeni vo hepatalnoto tkivo. Naj~esta pri~ina za hepatalna steatoza kaj vozrasnite e alkoholnata hepatalna bolest, koja e retka vo detskata populacija, no moè da se sretne vo adolescentnata vozrast. Vo detskata vozrast stetozata moè da nastane kako posledica na dejstvoto na nekoi lekovi kako [to e metotrehatot, vo sklop na mnogubrojni nasledni zaboluvawa, no stanuva se po~esta pojava kaj obeznite deca i sostojbi vo koi e naru[eno dejstvoto na insulinot. Vo sklop na ovie sostojbi se narekuva ne-alkoholna masna bolest na heparot (non – alchocolic fatty liver disease - NAFLD). Glavna tema na ova poglavje e NAFLD. Mikrovezikularnata steatoza naj~esto nastanuva vo sklop bolesti na mitohondrite ili kako posledica na toksi~noto dejstvo na valproatot. NAFLD kaj vozrasni Kako poseben entitet NAFLD za prv pat e opi[an vo 1970 godina kako hroni~na hepatalna bolest asocirana so obeznost (ponekoga[ pridruèna so hiperlipidemija i insulin-nezavisen dijabet). Ovoj entitet primarno bil ozna~en kako nealkoholen steatohepatitis (nonalchocolic steatohepatitis – NASH), poradi sli~nite histolo[ki obel`ja so alkoholniot hepatitis. Vo ponovo vreme se koristi terminot nealkoholna masna bolest na heparot, koja ozna~uva spektrum na sostojbi od ednostavna hepatalna steatoza bez inflamacija, nealkoholen steatohepatitis, do progresivna ciroza vo koja steatozata ne e veke prominentno obele`je. NAFLD ima visoka prevalenca vo adultnata populacija, so mnogu pogolem procent kaj obeznite luge (BMI>30) i pacientite so tip II Dijabetes melitus, no ne se site pacienti obezni. Steatozata moè da bide asimptomatska ili da se manifestira so nespecifi~ni konstitucionalni simptomi. Serumskite aminotransferazi se umereno poka~eni, bilirubinot e normalen, a biohemiski karakteristiki Страна 91
Page 1 and 2:
NOVINI VO PEDIJATRIJATA GODI{NA REV
Page 3:
Od glavniot redaktor Po~ituvani kol
Page 6 and 7:
Mladenović M, Radlović N, Lekovi
Page 8 and 9:
Milena C. Lo Giudice Although all t
Page 10 and 11:
Milena C. Lo Giudice patient will h
Page 12 and 13:
Milena C. Lo Giudice have on the ch
Page 14 and 15:
Страна 14
Page 16 and 17:
Nedeqko Radlovi] nje. Budući da su
Page 18 and 19:
Nedeqko Radlovi] (maksimalno 15 mg
Page 20 and 21:
Gjeorgjina Kuli-Lito Introduction K
Page 22 and 23:
Gjeoorgjina Kuli-Liito The fever ty
Page 24 and 25:
Gjeorgjina Kuli-Lito stenoses in ch
Page 26 and 27:
Страна 26
Page 28 and 29:
@eqko Ron~evi] Will stethoscope sur
Page 30 and 31:
@eqko Ron~evi] Electronic stethosco
Page 32 and 33:
@eqko Ron~evi] 8. Mangione S, Duffy
Page 34 and 35:
Nada Pop-Jordanova a critical role
Page 36 and 37:
Nada Pop-Jordanova response (long-t
Page 38 and 39:
Nada Pop-Jordanova In the following
Page 40 and 41: Nada Pop-Jordanova From Fig. 4 it i
Page 42 and 43: Nada Pop-Jordanova References: [1]
Page 44 and 45: Nada Pop-Jordanova [22] Friesen GM,
Page 46 and 47: Mirjana Ko~ova Ha[imoto tiroiditis
Page 48 and 49: Mirjana Ko~ova Slika 2. Devoj~e na
Page 50 and 51: Mirjana Ko~ova c) Ultrazvu~niot pre
Page 52 and 53: Mirjana Ko~ova smetaat deka kaj ovi
Page 54 and 55: Mirjana Ko~ova 10. Pituitary pseudo
Page 56 and 57: Страна 56
Page 58 and 59: Qup~o Nikolovski Summary: Regardles
Page 60 and 61: Qup~o Nikolovski Sugeriran antibiot
Page 62 and 63: Qup~o Nikolovski - Toj moè da se k
Page 64 and 65: Qup~o Nikolovski Sugeriran reìm Pr
Page 66 and 67: Qup~o Nikolovski decata so akcent n
Page 68 and 69: Qup~o Nikolovski Antibiotici i dija
Page 72 and 73: Sowa Peova Abstrakt Efikasno rano o
Page 74 and 75: Sowa Peova Ranoto klini~ko prepozna
Page 76 and 77: Sowa Peova - In vitro analiza na in
Page 78 and 79: Sowa Peova metodi pred da se pojava
Page 80 and 81: Sowa Peova Страна 80
Page 84 and 85: Dafina Kuzmanovska bubre`na insufic
Page 86 and 87: Dafina Kuzmanovska 1. Abnormalen ra
Page 88 and 89: Dafina Kuzmanovska Isto taka, nema
Page 92 and 93: Aco Kostovski na holestaza ne se pr
Page 94 and 95: Aco Kostovski dukcijata na SREBP -
Page 96 and 97: Aco Kostovski niraat sintezata na l
Page 98 and 99: Aco Kostovski lema neselektirana st
Page 100 and 101: Aco Kostovski 2. Tip 1 ili 2 diabet
Page 102 and 103: Aco Kostovski parcijalna lipodistro
Page 104 and 105: Aco Kostovski patis od drugi mo`ni
Page 106 and 107: Aco Kostovski Lipoproteini so mala
Page 108 and 109: Aco Kostovski kontrola na obeznosta
Page 110 and 111: Aco Kostovski za razlika od general
Page 112 and 113: Aco Kostovski NEALKOHOLNA MASTNA BO
Page 114 and 115: Lekovi] Z. SY GILBERT IN CHILDREN:
Page 118 and 119: Aspazija Sofijanova ABSTRAKT Mnogu
Page 120 and 121: Aspazija Sofijanova en~iwa. Zatoa d
Page 122 and 123: Aspazija Sofijanova Odgovor na Krat
Page 124 and 125: Aspazija Sofijanova cira so seriozn
Page 126 and 127: Aspazija Sofijanova sporo. Hepati~n
Page 128 and 129: Aspazija Sofijanova asociran so pos
Page 130 and 131: Aspazija Sofijanova 16. Meyer PG, O
Page 132 and 133: Aspazija Sofijanova 48. Goldman HB.
Page 136 and 137: Du[ko Fidanovski Abstract With intr
Page 138 and 139: Du[ko Fidanovski dilna teìna od 50
Page 140 and 141:
Du[ko Fidanovski koncentracii pomal
Page 142 and 143:
Du[ko Fidanovski Lekuvawe so surfak
Page 144 and 145:
Du[ko Fidanovski EMRT i golem rizik
Page 146 and 147:
Du[ko Fidanovski 17. Kotecha S, Wil
Page 148 and 149:
Du[ko Fidanovski 46. Corbet A, Long
Page 150 and 151:
Страна 150
Page 152 and 153:
Filip Duma fluid. Precise diagnose
Page 154 and 155:
Filip Duma rata i mozo~noto tkivo,
Page 156 and 157:
Filip Duma Diskusija i rezultati: K
Page 158 and 159:
Kata Martinova endokrinite `lezdi i
Page 160 and 161:
Kata Martinova Evaluacija i monitor
Page 162 and 163:
Kata Martinova SQUID (superconducti
Page 164 and 165:
Kata Martinova sostojba da odrùva
Page 166 and 167:
Kata Martinova 10. Grady RW., Berdo
Page 168 and 169:
Vladimir âdikovski The computer th
Page 170 and 171:
Vladimir âdikovski 5. Should peopl
Page 172 and 173:
Nadica Ristoska Bojkovska Istorijat
Page 174 and 175:
Nadica Ristoska Bojkovska � Virus
Page 176 and 177:
Nadica Ristoska Bojkovska na CMV in
Page 178 and 179:
Nadica Ristoska Bojkovska Takrolimu
Page 180 and 181:
Nadica Ristoska Bojkovska Literatur
Page 182 and 183:
Velibor Tasi] Hipourikemija e labor
Page 184 and 185:
Velibor Tasi] Ovoj lek go zgolemuva
Page 186 and 187:
Velibor Tasi] diabetes mellitus, ma
Page 188 and 189:
Страна 188
Page 190 and 191:
Emilija Vla[ki diagnostic investiga
Page 192 and 193:
Emilija Vla[ki pnevmociti so difuzn
Page 194 and 195:
Emilija Vla[ki dijagnosti~koto zna~
Page 196 and 197:
Emilija Vla[ki na~eni promeni treba
Page 198 and 199:
Katarina Stavri] na prisustvoto na
Page 200 and 201:
Katarina Stavri] fagite i eozinofil
Page 202 and 203:
Katarina Stavri] telite i decata do
Page 204 and 205:
Страна 204
Page 206 and 207:
Katerina Obo~ki What is the Practal
Page 208 and 209:
Katerina Obo~ki Tret fakt: izloèno
Page 210 and 211:
Katerina Obo~ki - izbegnuvawe na ek
Page 212:
Katerina Obo~ki Zaklu~ok: Sekoga[ t
show all

Conduct disorder

Create successful ePaper yourself

Delete template?

Save as template?